Lead Product(s) : 4-Phenyl Butyric Acid
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 17, 2019
Lead Product(s) : 4-Phenyl Butyric Acid
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable